Actively Recruiting
Patterns of LDL Cholesterol Reduction After Starting Ezetimibe Treatment in Adults A Study of Treatment Response and Predictors
Led by Universidade do Porto · Updated on 2026-09-24
100
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating why some adults have a larger decrease in low-density lipoprotein cholesterol LDL-C, often called bad cholesterol, after starting treatment with ezetimibe. This medicine is used to lower cholesterol levels when current treatment is not enough. The study aims to understand how factors like diet, salt intake, physical activity, and personal health affect the amount LDL-C levels drop after starting ezetimibe. This research is a phase 4, open-label, interventional trial conducted in routine clinical practice. Participants will begin ezetimibe treatment at the standard dose of 10 mg once daily. The medication may be used alone or added to stable background cholesterol-lowering therapy without changing the type or dose of other medications. The study will assess lipid response by measuring cholesterol levels before and after starting ezetimibe, along with collecting information on diet using a food questionnaire and 24-hour urine samples, and evaluating physical activity with a validated questionnaire. During the study, participants will have blood tests to measure LDL-C, non-HDL cholesterol, and apolipoprotein B at least 8 weeks after beginning ezetimibe. Researchers will also analyze urine samples and questionnaire data to find lifestyle and clinical factors that predict how much LDL-C decreases. The goal is to help doctors personalize cholesterol treatment by identifying who benefits most from ezetimibe. The study is expected to be completed by April 2027.
CONDITIONS
Brief Title
LDL Cholesterol Reduction Following Ezetimibe Initiation
Research Team
P
Pedro Marques, MD.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here